Active stabilization of human endothelial nitric oxide synthase mRNA by hnRNP E1 protects against antisense RNA and microRNAs

Molecular and Cellular Biology

Volumn 33, Issue 10, 2013, Pages 2029-2046

  David Ho, J J ^a,b   Robb, G Brett ^a,c   Tai, Sharon C ^b   Turgeon, Paul J ^a,b   Mawji, Imtiaz A ^b   Man, H S Jeffrey ^a,b   Marsdena, Philip A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c New England Biolabs   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; MICRORNA; PROTEIN KINASE B; PYRIMIDINE; SMALL INTERFERING RNA; DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; NOS3 PROTEIN, HUMAN; PCBP1 PROTEIN, HUMAN; RIBONUCLEASE III; RIBONUCLEOPROTEIN;

3' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HALF LIFE TIME; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOPRECIPITATION; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANTIOXIDANT RESPONSIVE ELEMENT; BINDING SITE; CELL CULTURE; CELL HYPOXIA; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; RABBIT; RNA INTERFERENCE; RNA STABILITY; UMBILICAL VEIN ENDOTHELIAL CELL;

3' UNTRANSLATED REGIONS; ANIMALS; ANTIOXIDANT RESPONSE ELEMENTS; BASE SEQUENCE; BINDING SITES; CELL HYPOXIA; CELLS, CULTURED; DEAD-BOX RNA HELICASES; HALF-LIFE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MICRORNAS; MOLECULAR SEQUENCE DATA; NITRIC OXIDE SYNTHASE TYPE III; RABBITS; RIBONUCLEASE III; RIBONUCLEOPROTEINS; RNA INTERFERENCE; RNA STABILITY; RNA, MESSENGER; RNA, SMALL INTERFERING;

MLCS; MLOWN;

EID: 84878992840     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01257-12     Document Type: Article

References (71)

1. Yetik-Anacak G, Catravas JD. 2006. Nitric oxide and the endothelium: history and impact on cardiovascular disease. Vascul. Pharmacol. 45:268-276.
2. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239-242.
3. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O. 1996. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 93:13176-13181.
4. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC. 1998. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J. Clin. Invest. 101:731-736.
5. Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, Marsden PA. 1997. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler. Thromb. Vasc. Biol. 17:2479-2488.
6. Faller DV. 1999. Endothelial cell responses to hypoxic stress. Clin. Exp. Pharmacol. Physiol. 26:74-84.
7. Ho JJ, Man HS, Marsden PA. 2012. Nitric oxide signaling in hypoxia. J. Mol. Med. 90:217-231.
8. Tai SC, Robb GB, Marsden PA. 2004. Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel. Arterioscler. Thromb. Vasc. Biol. 24:405-412.
9. McQuillan LP, Leung GK, Marsden PA, Kostyk SK, Kourembanas S. 1994. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am. J. Physiol. 267:H1921-H1927.
10. Ziesche R, Petkov V, Williams J, Zakeri SM, Mosgoller W, Knofler M, Block LH. 1996. Lipopolysaccharide and interleukin 1 augment the effects of hypoxia and inflammation in human pulmonary arterial tissue. Proc. Natl. Acad. Sci. U. S. A. 93:12478-12483.
11. Fish JE, Matouk CC, Yeboah E, Bevan SC, Khan M, Patil K, Ohh M, Marsden PA. 2007. Hypoxia-inducible expression of a natural cisantisense transcript inhibits endothelial nitric-oxide synthase. J. Biol. Chem. 282:15652-15666.
12. Flowers MA, Wang Y, Stewart RJ, Patel B, Marsden PA. 1995. Reciprocal regulation of endothelin-1 and endothelial constitutive NOS in proliferating endothelial cells. Am. J. Physiol. 269:H1988-H1997.
13. Yoshizumi M, Perrella MA, Burnett JC, Jr, Lee ME. 1993. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73:205-209.
14. Yan G, You B, Chen SP, Liao JK, Sun J. 2008. Tumor necrosis factoralpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1. Circ. Res. 103:591-597.
15. Lu JL, Schmiege LM, III, Kuo L, Liao JC. 1996. Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide. Biochem. Biophys. Res. Commun. 225:1-5.
16. Liao JK, Shin WS, Lee WY, Clark SL. 1995. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem. 270:319-324.
17. Robb GB, Carson AR, Tai SC, Fish JE, Singh S, Yamada T, Scherer SW, Nakabayashi K, Marsden PA. 2004. Post-transcriptional regulation of endothelial nitric-oxide synthase by an overlapping antisensemRNAtranscript. J. Biol. Chem. 279:37982-37996.
18. Yamada T, Carson AR, Caniggia I, Umebayashi K, Yoshimori T, Nakabayashi K, Scherer SW. 2005. Endothelial nitric-oxide synthase antisense (NOS3AS) gene encodes an autophagy-related protein (APG9- like2) highly expressed in trophoblast. J. Biol. Chem. 280:18283-18290.
19. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
20. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233.
21. Carthew RW, Sontheimer EJ. 2009. Origins and mechanisms of miRNAs and siRNAs. Cell 136:642-655.
22. Friedman RC, Farh KK, Burge CB, Bartel DP. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19:92-105.
23. Chaudhury A, Chander P, Howe PH. 2010. Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: focus on hnRNP E1's multifunctional regulatory roles. RNA 16:1449-1462.
24. Kourembanas S, Marsden PA, McQuillan LP, Faller DV. 1991. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J. Clin. Invest. 88:1054-1057.
25. Dumont DJ, Gradwohl GJ, Fong GH, Auerbach R, Breitman ML. 1993. The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors. Oncogene 8:1293-1301.
26. Marsden PA, Sultan P, Cybulsky M, Gimbrone MA, Jr, Brenner BM, Collins T. 1992. Nucleotide sequence of endothelin-1 cDNA from rabbit endothelial cells. Biochim. Biophys. Acta 1129:249-250.
27. Marsden PA, Schappert KT, Chen HS, Flowers M, Sundell CL, Wilcox JN, Lamas S, Michel T. 1992. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett. 307:287-293.
28. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappert KT. 1993. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268:17478-17488.
29. Gustin KE, Burk RD. 1993. A rapid method for generating linker scanning mutants utilizing PCR. Biotechniques 14:22, 24.
30. Teichert AM, Miller TL, Tai SC, Wang Y, Bei X, Robb GB, Phillips MJ, Marsden PA. 2000. In vivo expression profile of an endothelial nitric oxide synthase promoter-reporter transgene. Am. J. Physiol. Heart Circ. Physiol. 278:H1352-H1361.
31. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
32. Loflin PT, Chen CY, Xu N, Shyu AB. 1999. Transcriptional pulsing approaches for analysis of mRNA turnover in mammalian cells. Methods 17:11-20.
33. Ross J. 1995.mRNAstability in mammalian cells. Microbiol. Rev. 59:423-450.
34. Kiledjian M, Day N, Trifillis P. 1999. Purification and RNA binding properties of the polycytidylate-binding proteins alphaCP1 and alphaCP2. Methods 17:84-91.
35. Dandekar T, Stripecke R, Gray NK, Goossen B, Constable A, Johansson HE, Hentze MW. 1991. Identification of a novel iron-responsive element in murine and human erythroid delta-aminolevulinic acid synthase mRNA. EMBO J. 10:1903-1909.
36. Chkheidze AN, Lyakhov DL, Makeyev AV, Morales J, Kong J, Liebhaber SA. 1999. Assembly of the alpha-globin mRNA stability complex reflects binary interaction between the pyrimidine-rich 3= untranslated region determinant and poly(C) binding protein alphaCP. Mol. Cell. Biol. 19:4572-4581.
37. Ho JJ, Metcalf JL, Yan MS, Turgeon PJ, Wang JJ, Chalsev M, Petruzziello-Pellegrini TN, Tsui AK, He JZ, Dhamko H, Man HS, Robb GB, Teh BT, Ohh M, Marsden PA. 2012. Functional importance of dicer protein in the adaptive cellular response to hypoxia. J. Biol. Chem. 287: 29003-29020.
38. Fish JE, Yan MS, Matouk CC, St Bernard R, Ho JJ, Gavryushova A, Srivastava D, Marsden PA. 2010. Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones. J. Biol. Chem. 285:810-826.
39. Liebhaber SA. 1989. Alpha thalassemia. Hemoglobin 13:685-731.
40. Wang X, Kiledjian M, Weiss IM, Liebhaber SA. 1995. Detection and characterization of a 3= untranslated region ribonucleoprotein complex associated with human alpha-globin mRNA stability. Mol. Cell. Biol. 15: 1769-1777.
41. Morales J, Russell JE, Liebhaber SA. 1997. Destabilization of human alpha-globin mRNA by translation anti-termination is controlled during erythroid differentiation and is paralleled by phased shortening of the poly(A) tail. J. Biol. Chem. 272:6607-6613.
42. Zhang W, Wagner BJ, Ehrenman K, Schaefer AW, DeMaria CT, Crater D, DeHaven K, Long L, Brewer G. 1993. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 13:7652-7665.
43. Lagnado CA, Brown CY, Goodall GJ. 1994. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Mol. Cell. Biol. 14:7984-7995.
44. Zubiaga AM, Belasco JG, Greenberg ME. 1995. The nonamer UUAUU UAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol. Cell. Biol. 15:2219-2230.
45. Lewis T, Gueydan C, Huez G, Toulme JJ, Kruys V. 1998. Mapping of a minimal AU-rich sequence required for lipopolysaccharide-induced binding of a 55-kDa protein on tumor necrosis factor-alpha mRNA. J. Biol. Chem. 273:13781-13786.
46. Chen CY, Shyu AB. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:465-470.
47. Wilson GM, Brewer G. 1999. The search for trans-acting factors controlling messenger RNA decay. Prog. Nucleic Acid Res. Mol. Biol. 62:257-291.
48. Holcik M, Liebhaber SA. 1997. Four highly stable eukaryotic mRNAs assemble 3= untranslated region RNA-protein complexes sharing cis and trans components. Proc. Natl. Acad. Sci. U. S. A. 94:2410-2414.
49. Kiledjian M, Wang X, Liebhaber SA. 1995. Identification of two KH domain proteins in the alpha-globin mRNP stability complex. EMBO J. 14:4357-4364.
50. Wang X, Liebhaber SA. 1996. Complementary change in cis determinants and trans factors in the evolution of an mRNP stability complex. EMBO J. 15:5040-5051.
51. Habelhah H, Shah K, Huang L, Ostareck-Lederer A, Burlingame AL, Shokat KM, Hentze MW, Ronai Z. 2001. ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat. Cell Biol. 3:325-330.
52. Chkheidze AN, Liebhaber SA. 2003. A novel set of nuclear localization signals determine distributions of the alphaCP RNA-binding proteins. Mol. Cell. Biol. 23:8405-8415.
53. Ji X, Kong J, Liebhaber SA. 2003. In vivo association of the stability control protein alphaCP with actively translating mRNAs. Mol. Cell. Biol. 23:899-907.
54. Ostrowski J, Bomsztyk K. 2003. Nuclear shift of hnRNP K protein in neoplasms and other states of enhanced cell proliferation. Br. J. Cancer 89:1493-1501.
55. Suarez Y, Fernandez-Hernando C, Pober JS, Sessa WC. 2007. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ. Res. 100:1164-1173.
56. Chaudhury A, Hussey GS, Ray PS, Jin G, Fox PL, Howe PH. 2010. TGF-beta-mediated phosphorylation of hnRNP E1 inducesEMTvia transcript-selective translational induction of Dab2 and ILEI. Nat. Cell Biol. 12:286-293.
57. Meng Q, Rayala SK, Gururaj AE, Talukder AH, O'Malley BW, Kumar R. 2007. Signaling-dependent and coordinated regulation of transcription, splicing, and translation resides in a single coregulator, PCBP1. Proc. Natl. Acad. Sci. U. S. A. 104:5866-5871.
58. Mohr E, Richter D. 2001. Messenger RNA on the move: implications for cell polarity. Int. J. Biochem. Cell Biol. 33:669-679.
59. Wormington M, Searfoss AM, Hurney CA. 1996. Overexpression of poly(A) binding protein prevents maturation-specific deadenylation and translational inactivation in Xenopus oocytes. EMBO J. 15:900-909.
60. Aoki K, Matsumoto K, Tsujimoto M. 2003. Xenopus cold-inducible RNA-binding protein 2 interacts with ElrA, the Xenopus homolog of HuR, and inhibits deadenylation of specific mRNAs. J. Biol. Chem. 278: 48491-48497.
61. Makeyev AV, Chkheidze AN, Liebhaber SA. 1999. A set of highly conserved RNA-binding proteins, alphaCP-1 and alphaCP-2, implicated in mRNA stabilization, are coexpressed from an intronless gene and its intron-containing paralog. J. Biol. Chem. 274:24849-24857.
62. Makeyev AV, Liebhaber SA. 2000. Identification of two novel mammalian genes establishes a subfamily of KH-domain RNA-binding proteins. Genomics 67:301-316.
63. Waggoner SA, Liebhaber SA. 2003. Identification of mRNAs associated with alphaCP2-containing RNP complexes. Mol. Cell. Biol. 23:7055-7067.
64. Waggoner SA, Liebhaber SA. 2003. Regulation of alpha-globin mRNA stability. Exp. Biol. Med. 228:387-395.
65. Stefanovic B, Hellerbrand C, Holcik M, Briendl M, Aliebhaber S, Brenner DA. 1997. Posttranscriptional regulation of collagen alpha1(I) mRNA in hepatic stellate cells. Mol. Cell. Biol. 17:5201-5209.
66. Czyzyk-Krzeska MF, Beresh JE. 1996. Characterization of the hypoxia-inducible protein binding site within the pyrimidine-rich tract in the 3=-untranslated region of the tyrosine hydroxylase mRNA. J. Biol. Chem. 271:3293-3299.
67. Czyzyk-Krzeska MF, Bendixen AC. 1999. Identification of the poly(C) binding protein in the complex associated with the 3= untranslated region of erythropoietin messenger RNA. Blood 93:2111-2120.
68. Ostareck-Lederer A, Ostareck DH, Standart N, Thiele BJ. 1994. Translation of 15-lipoxygenase mRNA is inhibited by a protein that binds to a repeated sequence in the 3= untranslated region. EMBO J. 13:1476-1481.
69. Ostareck DH, Ostareck-Lederer A, Wilm M, Thiele BJ, Mann M, Hentze MW. 1997. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3= end. Cell 89:597-606.
70. Siomi H, Dreyfuss G. 1995. A nuclear localization domain in the hnRNP A1 protein. J. Cell Biol. 129:551-560.
71. Gamarnik AV, Andino R. 1997. Two functional complexes formed by KH domain containing proteins with the 5= noncoding region of poliovirus RNA. RNA 3:882-892.